GlassScriptPhysician profile
Jessica Rice
NPI 1992278394
$14,532.32
in general payments reported to CMS, 2019-2025
34 companies · $8,580 in 2025
The $8,580 reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $1,278 · 2023: $1,372 · 2024: $2,924 · 2025: $8,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $2,250 · Travel and Lodging: $62.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,562.50 |
| Food and Beverage | $2,249.98 |
| Travel and Lodging | $62.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11,899.74 | 2021-2025 | |
| Lundbeck LLC | $284.65 | 2022-2023 | Vyepti |
| Novartis Pharmaceuticals Corporation | $243.16 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $198.68 | 2023 | Nuedexta |
| Teva Pharmaceuticals USA, INC. | $154.21 | 2022-2025 | Ajovy, Austedo Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $152.63 | 2022 | |
| Amgen INC. | $145.68 | 2022-2024 | Uplizna, Aimovig, Repatha |
| Sk Life Science, INC. | $144.12 | 2021-2023 | |
| Ani Pharmaceuticals, INC. | $125.97 | 2022-2023 | Purified Cortrophin Gel |
| Alexion Pharmaceuticals, INC. | $92.39 | 2023 | Ultomiris |
| Csl Behring | $88.92 | 2022 | |
| Ucb, INC. | $81.59 | 2022-2025 | Briviact |
| Lilly USA, LLC | $81.19 | 2022-2025 | Emgality, Reyvow, Kisunla |
| Sunovion Pharmaceuticals INC. | $77.06 | 2022 | |
| Upsher-Smith Laboratories LLC | $69.80 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $58.99 | 2023-2024 | |
| Banner Life Sciences, LLC | $58.33 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.10 | 2022 | |
| Impel Pharmaceuticals INC. | $52.61 | 2022-2023 | Trudhesa |
| Eisai INC. | $49.06 | 2022 | |
| Xeris Pharmaceuticals, INC. | $46.80 | 2022 | |
| Avanir Pharmaceuticals, INC. | $46.50 | 2022 | |
| Biogen, INC. | $43.89 | 2023 | Vumerity, Tysabri |
| Neurocrine Biosciences, INC. | $37.38 | 2022-2023 | Ingrezza, Ongentys |
| Ge Healthcare | $36.87 | 2024 | |
| Emd Serono, INC. | $34.39 | 2022-2023 | Bavencio |
| Mallinckrodt Hospital Products INC. | $33.32 | 2023 | Acthar |
| Biohaven Pharmaceuticals, INC. | $29.43 | 2021 | |
| Genentech USA, INC. | $20.21 | 2025 | Ocrevus Zunovo |
| Horizon Therapeutics Plc | $20.11 | 2023 | Uplizna |
| Tanabe Pharma America, INC. | $18.35 | 2021 | |
| Boston Scientific Corporation | $18.14 | 2021 | |
| Acadia Pharmaceuticals INC | $15.08 | 2024 | Nuplazid |
| Currax Pharmaceuticals LLC | $14.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.